Treatment of Hodgkin's disease with autologous stem cell transplantation: analysis of results and prognostic factors in 341 patients from the Polish Lymphoma Research Group

被引：0
|
作者：
Czyz, J
Hellmann, A
Dziadziuszko, R
Kachel, L
Holowiecki, J
Gozdzik, J
Hansz, J
Avigdor, A
Nagler, A
Osowiecki, M
Walewski, J
Knopinska-Posluszny, W
Mensah, P
Jurczak, W
Skotnicki, A
Sedzimirska, M
Lange, A
Sawicki, W
Sulek, K
Wach, M
Dmoszynska, A
Kus, A
Warzocha, K
Robak, T
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA RELAPSING AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION-A POLISH LYMPHOMA RESEARCH GROUP (PLRG) MULTICENTER RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS AND LONG-TERM OUTCOME
    Czyz, A.
    Romejko-Jarosinska, J.
    Manko, J.
    Drab, E.
    Nasilowska-Adamska, B.
    Czerw, T.
    Giza, A.
    Knopinska-Posluszny, W.
    Drozd-Sokolowska, J.
    Stelmach, P.
    Dybko, J.
    Lojko-Dankowska, A.
    Hus, M.
    Walewski, J.
    Komarnicki, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S179 - S180
  • [2] Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
    Czyz, J
    Dziadziuszko, R
    Knopinska-Postuszuy, W
    Hellmann, A
    Kachel, L
    Holowiecki, J
    Gozdzik, J
    Hansz, J
    Avigdor, A
    Nagler, A
    Osowiecki, M
    Walewski, J
    Mensah, P
    Jurczak, W
    Skotnicki, A
    Sedzimirska, M
    Lange, A
    Sawicki, W
    Sulek, K
    Wach, M
    Dmoszynska, A
    Kus, A
    Robak, T
    Warzocha, K
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1222 - 1230
  • [3] Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†
    Martinez, C.
    Canals, C.
    Sarina, B.
    Alessandrino, E. P.
    Karakasis, D.
    Pulsoni, A.
    Sica, S.
    Trneny, M.
    Snowden, J. A.
    Kanfer, E.
    Milpied, N.
    Bosi, A.
    Guidi, S.
    de Souza, C. A.
    Willemze, R.
    Arranz, R.
    Jebavy, L.
    Hellmann, A.
    Sibon, D.
    Oneto, R.
    Luan, J. J.
    Dreger, P.
    Castagna, L.
    Sureda, A.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2430 - 2434
  • [4] Autologous stem cell transplantation in the treatment of Hodgkin's disease
    Tarabar, Olivera
    Tukic, Ljiljana
    Stamatovic, Dragana
    Balint, Bela
    Elez, Marija
    Ostojic, Gordana
    Tatomirovic, Zeljka
    Marjanovic, Slobodan
    VOJNOSANITETSKI PREGLED, 2009, 66 (07) : 571 - 576
  • [5] Prognostic Factors of Lymphoma Patients after Autologous Stem Cell Transplantation
    Qian, Fenghua
    Fan, Wenxia
    Wei, Xia
    Zhu, Yan
    Fu, Gang
    Qin, Dabing
    Tian, Xiaobo
    Pei, Li
    Xu, Shuangnian
    Chen, Jieping
    Zhang, Yong
    ANNALS OF TRANSPLANTATION, 2015, 20 : 225 - 232
  • [6] Prognostic factors and autologous haematopoietic stem cell transplantation in lymphoma patients
    Mikhaylova, NB
    Zoubarovskaya, LS
    Zaritsky, AY
    Afanasyev, BV
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S251
  • [7] High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group
    J Czyż
    A Hellmann
    R Dziadziuszko
    J Hansz
    J Goździk
    J Hołowiecki
    B Stella-Hołowiecka
    Ł Kachel
    W Knopińska-Posłuszny
    A Nagler
    J Meder
    J Walewski
    E Lampka
    K Sułek
    W Sawicki
    A Lange
    K Forgacz
    K Suchnicki
    T Pacuszko
    A Skotnicki
    P Mensah
    W Jurczak
    K Kuliczkowski
    T Wróbel
    G Mazur
    A Dmoszyńska
    M Wach
    T Robak
    K Warzocha
    Bone Marrow Transplantation, 2002, 30 : 29 - 34
  • [8] High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease.: Retrospective study of the Polish Lymphoma Research Group
    Czyz, J
    Hellmann, A
    Dziadziuszko, R
    Hansz, J
    Gozdzik, J
    Holowiecki, J
    Stella-Holowiecka, B
    Kachel, L
    Knopinska-Posluszny, W
    Nagler, A
    Meder, J
    Walewski, J
    Lampka, E
    Sulek, K
    Sawicki, W
    Lange, A
    Forgacz, K
    Suchnicki, K
    Pacuszko, T
    Skotnicki, A
    Mensah, P
    Jurczak, W
    Kuliczkowski, K
    Wróbel, T
    Mazur, G
    Dmoszynska, A
    Wach, M
    Robak, T
    Warzocha, K
    BONE MARROW TRANSPLANTATION, 2002, 30 (01) : 29 - 34
  • [9] Prognostic factors, clinical outcome and survival of patients with relapsed or refractory Hodgkin's lymphoma after autologous stem cell transplantation
    Gaudio, F.
    Pastore, D.
    Delia, M.
    Perrone, T.
    Curci, P.
    Laddaga, F. E.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S435 - S435
  • [10] Relapse of Hodgkin's lymphoma after autologous stem cell transplantation: prognostic factors in 462 patients registered in the database of the EBMT
    Martinez, C.
    Canals, C.
    Alessandrino, E.
    Karakasis, D.
    Pulsoni, A.
    Leone, G.
    Trneny, M.
    Snowden, J.
    Kanfer, E.
    Milpied, N.
    Bosi, A.
    Caselli, D.
    de Souza, C. A.
    Luan, J.
    Oneto, R.
    Willemze, R.
    Arranz, R.
    Jebavy, L.
    Hellmann, A.
    Sibon, D.
    Sureda, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S44 - S45
12345